AI Scientists Are Only as Good as Their Evidence: A Stratified Ablation of Proprietary Data and Reasoning Skills in Drug-Asset Valuation
AI Scientist agents are often evaluated as if capability were mainly a function of model quality, prompting, or reasoning scaffolds. We test a different hypothesis in drug-asset valuation: for knowledge-intensive scientific decisions, the limiting factor is often the evidence…